These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4711 related articles for article (PubMed ID: 6169659)

  • 41. ADCC of cultured human melanoma cells: analysis with monoclonal antibodies to human melanoma-associated antigens.
    Imai K; Ng AK; Glassy MC; Ferrone S
    Scand J Immunol; 1981 Oct; 14(4):369-77. PubMed ID: 7336169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97.
    Casellas P; Brown JP; Gros O; Gros P; Hellström I; Jansen FK; Poncelet P; Roncucci R; Vidal H; Hellström KE
    Int J Cancer; 1982 Oct; 30(4):437-43. PubMed ID: 7141740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.
    Adams DO; Hall T; Steplewski Z; Koprowski H
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3506-10. PubMed ID: 6587365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
    Kaneko MK; Nakamura T; Kunita A; Fukayama M; Abe S; Nishioka Y; Yamada S; Yanaka M; Saidoh N; Yoshida K; Fujii Y; Ogasawara S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):104-112. PubMed ID: 28504613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies.
    Schnueriger A; Grau R; Sondermann P; Schreitmueller T; Marti S; Zocher M
    Mol Immunol; 2011 Jul; 48(12-13):1512-7. PubMed ID: 21570725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.
    Seeger RC; Rosenblatt HM; Imai K; Ferrone S
    Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors.
    Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L
    Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
    Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
    Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current status of monoclonal antibodies to human melanoma and its application].
    Imai K; Adachi M; Yachi A
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):852-60. PubMed ID: 6192770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple assay characterization of murine monoclonal antimelanoma antibodies.
    Stuhlmiller GM; Borowitz MJ; Croker BP; Seigler HF
    Hybridoma; 1982; 1(4):447-60. PubMed ID: 6208139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficient selection of human tumor growth-inhibiting monoclonal antibodies.
    Herlyn D; Herlyn M; Ross AH; Ernst C; Atkinson B; Koprowski H
    J Immunol Methods; 1984 Oct; 73(1):157-67. PubMed ID: 6491298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the pancreas.
    Bosslet K; Kern HF; Kanzy EJ; Steinstraesser A; Schwarz A; Lüben G; Schorlemmer HU; Sedlacek HH
    Cancer Immunol Immunother; 1986; 23(3):185-91. PubMed ID: 3539336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exchanging human Fcgamma1 with murine Fcgamma2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model.
    Lutterbuese P; Brischwein K; Hofmeister R; Crommer S; Lorenczewski G; Petersen L; Lippold S; da Silva A; Locher M; Baeuerle PA; Schlereth B
    Cancer Immunol Immunother; 2007 Apr; 56(4):459-68. PubMed ID: 16937114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma.
    Magnani JL; Brockhaus M; Smith DF; Ginsburg V; Blaszczyk M; Mitchell KF; Steplewski Z; Koprowski H
    Science; 1981 Apr; 212(4490):55-6. PubMed ID: 7209516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects.
    Luo W; Ko E; Hsu JC; Wang X; Ferrone S
    J Immunol; 2006 May; 176(10):6046-54. PubMed ID: 16670313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.
    Sung MW; Yasumura S; Johnson JT; Van Dongen GA; Whiteside TL
    Int J Cancer; 1995 Jun; 61(6):864-72. PubMed ID: 7790123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal antibodies to tumor antigens.
    Hellström KE; Brown JP; Hellström I
    Contemp Top Immunobiol; 1980; 11():117-37. PubMed ID: 6160947
    [No Abstract]   [Full Text] [Related]  

  • 59. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
    Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
    Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
    [No Abstract]   [Full Text] [Related]  

  • 60. Immune responses in human colon cancer. II. Cytotoxic antibody detected in patients' sera.
    Hahn WV; Kagnoff MF; Hatlen LH
    J Natl Cancer Inst; 1978 Apr; 60(4):779-84. PubMed ID: 75979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 236.